InsiderSignal.AI

InsiderSignal.ai

CHE - Chemed Corp

Insider Sale by McNamara Kevin J (Pres, CEO)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

4 days ago, McNamara Kevin J, serving as Pres, CEO at Chemed Corp (CHE), sold 2,000 shares at $421.13 per share, for a total transaction value of $842,260.00. Following this transaction, McNamara Kevin J now holds 90,219 shares of CHE.

This sale represents a 2.00% decrease in McNamara Kevin J's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Friday, May 1, 2026 and publicly disclosed via SEC Form 4 filing on Monday, May 4, 2026, 3 days after the trade was made.

Chemed Corp operates in the HEALTHCARE sector, specifically within the MEDICAL CARE FACILITIES industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

McNamara Kevin J

McNamara Kevin J

Pres, CEO

Kevin J. McNamara is the President, Chief Executive Officer, and Director of Chemed Corp (NYSE: CHE), a position he has held since April 30, 2001.[[1]](https://www.marketscreener.com/insider/KEVIN-MCNAMARA-A02GQU/)[[3]](https://portersfiveforce.com/blogs/owners/chemed) He also serves as Chairman of VITAS Healthcare Corp., a key subsidiary of Chemed focused on hospice care.[[1]](https://www.marketscreener.com/insider/KEVIN-MCNAMARA-A02GQU/) As the largest individual insider shareholder, McNamara owns approximately 101,197 shares valued at over $56 million as of mid-2025, aligning his interests closely with public shareholders.[[4]](https://www.gurufocus.com/insider/82207/kevin-j-mcnamara)[[3]](https://portersfiveforce.com/blogs/owners/chemed) McNamara brings over 35 years of leadership experience across healthcare, consumer services, and industrial sectors.[[2]](https://inst.shingo.org/directory/kevin-mcnamara/) Previously, he was President and CEO of Roto-Rooter Group, Inc., a Chemed subsidiary providing plumbing services, and Chief Operating Officer and Executive Vice President at Omnicare, Inc., until 1991.[[1]](https://www.marketscreener.com/insider/KEVIN-MCNAMARA-A02GQU/) His early career included sales and marketing roles at Procter & Gamble, Pepsi-Cola, and E.J. Brach Corporation.[[2]](https://inst.shingo.org/directory/kevin-mcnamara/) McNamara earned an undergraduate degree from Denison University and a graduate degree from Cornell Law School.[[1]](https://www.marketscreener.com/insider/KEVIN-MCNAMARA-A02GQU/) In 2023, his total compensation at Chemed exceeded $12.6 million.[[4]](https://www.gurufocus.com/insider/82207/kevin-j-mcnamara)

View full insider profile →

Trade Price

$421.13

Quantity

2,000

Total Value

$842,260.00

Shares Owned

90,219

Trade Date

Friday, May 1, 2026

4 days ago

SEC Filing Date

Monday, May 4, 2026

Filed 3 days after trade

HEALTHCAREMEDICAL CARE FACILITIES

Discussion

Sign in to join the discussion.
Loading comments…
View news mentioning CHE

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/6191954

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime